Gyre Therapeutics
GYRE
GYRE
78 hedge funds and large institutions have $56.5M invested in Gyre Therapeutics in 2020 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
1% less funds holding
Funds holding: 79 → 78 (-1)
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
31% less capital invested
Capital invested by funds: $81.8M → $56.5M (-$25.2M)
Holders
78
Holding in Top 10
2
Calls
$309K
Puts
$4K
Top Buyers
| 1 | +$3.71M | |
| 2 | +$819K | |
| 3 | +$723K | |
| 4 |
Goldman Sachs
New York
|
+$450K |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
+$231K |
Top Sellers
| 1 | -$1.65M | |
| 2 | -$1.28M | |
| 3 | -$888K | |
| 4 |
CCM
CAAS Capital Management
New York
|
-$868K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$593K |